Who to call at Indaptus Therapeutics, Inc., and when
Fundz watches for the moments Indaptus Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Indaptus Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Indaptus Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Indaptus Therapeutics, Inc.. With Fundz connected, it knows.
Indaptus Therapeutics, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
indaptusrx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Indaptus Therapeutics completed a private placement stock offering on September 29, 2026, raising approximately $24.0 million in gross proceeds through a Stock Purchase Agreement executed on September 8, 2026. This capital raise strengthens the company's financial position during a critical period for the biopharmaceutical firm.
Key Takeaways
Company raised $24.0 million in gross proceeds through private placement of common stock
Stock Purchase Agreement was executed on September 8, 2026, with closing required by September 29, 2026
2 more takeaways
Related Filings (2)
2 more filings from Indaptus Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Indaptus Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.